Users Stopping Weight-Loss Medications Regain Weight Far More Rapidly Compared to Dieters

New research reveals that patients who stop using popular weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who halt traditional lifestyle plans.

Research printed in a leading health publication shows that while overweight individuals often shed substantial amounts of their body weight while on the medication, the mass returns at an average rate of nearly a kilo each month after stopping.

"Users buying such drugs need to be cognizant of the danger of rapid weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain suggests a return to original weight in about one and a half years.

Comparing Therapies

The study, which reviewed 37 of studies involving over 9,000 of participants, contrasted the effects of these new drugs with conventional dieting.

Scientists point out that people who lose weight through diet and exercise generally have a less rapid weight regain—perhaps 0.1 kg a month—post-intervention.

The Reason for the Quick Rebound

Nutrition scientists propose the mechanism of the injections explains the amplified rebound.

The injections mimic a natural hormone called glucagon-like peptide-1, which controls appetite.

"Long-term administration of GLP-1 concentrations far above than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement results in hunger is uncontrolled, making binge eating a significant risk."

An Ongoing Disease?

The NHS recommend the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

Professionals say that, considering the significant potential of weight regain, the therapy should be considered long-term.

This view is reinforced by drug manufacturers, who say that the results "emphasize the chronic character of excess weight," similar to managing conditions like hypertension.

Patient Experiences

Users who have come off the medication describe a intense return of cravings.

"It was like a trigger that goes on and you're instantly extremely hungry," recalled one woman.

The struggle is compounded if patients have not developed lasting dietary or behavioural changes during treatment.

Growing Adoption

Figures show that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.

• Adoption is more common among women than males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the medications through private healthcare rather than the NHS.

Finally, clinicians caution that while these medications are effective tools for shedding pounds, they are not a magic solution and long-term success relies on combined behavioural management.